Skip to main content
ROIV logo

ROIV

Roivant Sciences Ltd.

$34.21

1.54%

Trade Ideas Performance

Latest Closed Trade Idea

$34.21

1.54%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

11

Social

61

About

Events of Roivant Sciences Ltd. (ROIV)

In the past six months, Roivant Sciences Ltd. (ROIV) stock has trended upwards by 40.76% and 41.88%, with its 52-week range from $14.50 to $42.50. Key events impacting the stock price include the announcement of positive results from the Phase 2 PHocus study of mosliciguat in patients with PH-ILD in September 2026, which caused the stock to surge 16%. Additionally, the FDA approved LISRAYA (brepocitinib) for adults with dermatomyositis in August 2026.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)